1. Exhaled nitric oxide in asthma: “Everything we have always wanted” or “Not quite ready for prime time?”

   • E. R. McFadden Jr

   Invited Commentary 22 June 2007 Pages: 237 - 238

2. Web alert

   OriginalPaper 22 June 2007 Pages: 239 - 240

3. Stevens-Johnson syndrome and toxic epidermal necrolysis

   • Steven J. Parrillo

   OriginalPaper 22 June 2007 Pages: 243 - 247

4. Mastocytosis: Advances in diagnosis and treatment

   • Susan I. Hungness
   • Cem Akin

   OriginalPaper 22 June 2007 Pages: 248 - 254

5. What’s new in blistering disorders?

   • Paru Chaudhari
   • M. Peter Marinkovich

   OriginalPaper 22 June 2007 Pages: 255 - 263

6. C1-inhibitor deficiencies (hereditary angioedema): Where are we with therapies?

   • R. J. Lock
   • M. M. Gompels

   OriginalPaper 22 June 2007 Pages: 264 - 269

7. Clinical trials report

   • Constance H. Katelaris

   Report 22 June 2007 Pages: 273 - 273

8. Plasmapheresis for chronic inflammatory demyelinating polyradiculoneuropathy

   • Man Mohan Mehndiratta
   • Avinash Chandra Singh

   OriginalPaper 22 June 2007 Pages: 274 - 279

9. The spectrum of multiple sclerosis

   • Robert N. S. Heard

   OriginalPaper 22 June 2007 Pages: 280 - 284

10. Immunology of multiple sclerosis

    • Michael P. Pender
    • Judith M. Greer

    OriginalPaper 22 June 2007 Pages: 285 - 292

11. Current management options in myasthenia gravis

    • Stephen Reddel

    OriginalPaper 22 June 2007 Pages: 293 - 300

12. The role of environmental tobacco smoke in the origins and progression of asthma

    • Neil C. Thomson

    OriginalPaper 22 June 2007 Pages: 303 - 309

13. Levalbuterol for asthma: A better treatment?

    • H. William Kelly

    OriginalPaper 22 June 2007 Pages: 310 - 314